{"id":241,"date":"2007-08-01T00:00:01","date_gmt":"2007-08-01T00:00:01","guid":{"rendered":"https:\/\/awge.doctime.es\/?p=241"},"modified":"2016-05-24T08:23:20","modified_gmt":"2016-05-24T06:23:20","slug":"awge-180","status":"publish","type":"post","link":"https:\/\/awge.doctime.es\/index.php\/2007\/08\/01\/awge-180\/","title":{"rendered":"Erythropoietin and intravenous iron therapy in postpartum anaemia"},"content":{"rendered":"

Acta Obstet Gynecol
\nElle W\u00e5gstr\u00f6m a; Agneta \u00c5kesson b; Marianne Van Rooijen c; Barbro Larson c; Katarina Bremme c
\nAcceso al enlace publicador<\/a><\/p>\n

Background. We assessed whether recombinant human erythropoietin (rhEPO) enhances a rise in haemoglobin concentration in postpartum anaemia compared to intravenous iron alone. Design. Some 60 patients with haemoglobin values80 g\/l were randomized within 72 h after parturition into 3 different treatment groups. All 3 groups were given a total dose of 450 mg intravenous iron sucrose. In addition, 2 groups were given 20,000 or 40,000 U of total rhEPO. All treatments were given on 2 occasions with an interval of 3 days (day 0 and 3). Results. Haemoglobin increased significantly in all 3 groups over time (p<0.001), and there were no differences between the different treatment groups on any day of evaluation (p=0.59). The total mean increment in haemoglobin in all subjects was 18 g\/l after 1 week, and 28 g\/l after 2 weeks. Conclusion. In comparison to intravenous iron alone, the addition of rhEPO did not further increase haemoglobin concentration in women with postpartum anaemia. \n\n<\/p>\n","protected":false},"excerpt":{"rendered":"